Page last updated: 2024-11-05

propylene oxide

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Occurs in Manufacturing Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

propylene oxide: structure [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

1,2-epoxypropane : An epoxide that is oxirane substituted by a methyl group at position 2. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID6378
CHEMBL ID2251584
CHEBI ID38685
MeSH IDM0053451

Synonyms (116)

Synonym
oxirane, methyl-
propylene oxide
ad 6 (suspending agent)
methyloxirane
propene oxide
2,3-epoxypropane
propylene epoxide
ad 6
methyl ethylene oxide
epoxypropane
75-56-9
1,2-propylene oxide
1,2-epoxypropane
ethylene oxide, methyl-
ccris 540
propane, epoxy-
hsdb 173
oxyde de propylene [french]
propylene oxide [un1280] [flammable liquid]
propyleneoxide
ai3-07541
epa pesticide chemical code 042501
brn 0079763
nci-c50099
einecs 200-879-2
un1280
methyl oxirane
caswell no. 713a
propane, 1,2-epoxy-
(+/-)-propylene oxide, reagentplus(r), 99%
(+/-)-propylene oxide, reagentplus(r), >=99%
2-methyloxirane
methyloxacyclopropane
CHEBI:38685 ,
propene epoxide
(+/-)-propylene oxide, puriss. p.a., >=99.5% (gc)
E0016
AKOS000121587
propylenoxide
propylene oxide (jan)
D09803
FT-0688180
oxyde de propylene
oxirane, 2-methyl-
ec 200-879-2
unii-y4y7nyd4bk
5-17-01-00017 (beilstein handbook reference)
propylene oxide [un1280] [flammable liquid]
y4y7nyd4bk ,
FT-0637313
AKOS017283338
propylene oxide [iarc]
(+/-)-1,2-epoxypropane
epihydrin
propylene oxide [jan]
propylene oxide [fcc]
propylene oxide [usp-rs]
1,2-propylene oxide [hsdb]
propylene oxide [mi]
dl-1,2-epoxypropane
CHEMBL2251584
J-502426
(+/-)-methyloxirane
1,2-epoxy propane
(rs)-methyloxirane
propeneoxide
1,2-epoxipropane
proplyene oxide
2-methyl-oxirane
(+/-)-propylene oxide
(rs)-propylene oxide
1,2-epoxy-propane
1,2-propylenoxide
rac-propylene oxide
(.+/-.)-methyloxirane
methylethylene oxide
un 1280
(.+/-.)-1,2-epoxypropane
3-methyl-1,2-epoxypropane
2-methyl oxirane
2-methyloxiran
F8880-5385
DTXSID5021207 ,
(+/-)-1,2-propylene oxide
mfcd00005126
(+/-)-propylene oxide, purum, >=99.0% (gc)
(+/-)-propylene oxide, >=99.5%
(+/-)-propylene oxide, analytical standard
(+/-)-propylene oxide, saj special grade, >=99.0%
propylene oxide, united states pharmacopeia (usp) reference standard
(+/-)-propylene oxide, 99.5%
(+/-)-propylene oxide, 99%
EN300-22338
methyl-oxirane
s(-)-methyloxirane
methyl-(s)-oxirane
epoxy-propane
methyl-ethylene oxide
STL511007
Q727742
BBL100026
FT-0777991
(r)-(+)-propyleneoxide
(+/-)-1,2-propylene-d6oxide
propylene oxide (dot:osha)
propane, epoxy
dtxcid301207
(+-)-epoxypropane
(+-)-1,2-epoxypropane
propylene oxide (usp-rs)
pesticide code: 042501.
propylene oxide (iarc)
(+-)-methyloxirane
caswell no 713a
dl-propylene oxide
(+-)-2-methyloxirane

Research Excerpts

Overview

Propylene oxide (PO) is an important industrial chemical used primarily in the synthesis of other compounds. Propylene oxide is a DNA-reactive genotoxic agent; that is, it reacts with DNA to produce lesions in the genetic material.

ExcerptReferenceRelevance
"Propylene oxide (PO) is an important industrial chemical used primarily in the synthesis of other compounds. "( Derivation of inhalation toxicity reference values for propylene oxide using mode of action analysis: example of a threshold carcinogen.
Albertini, RJ; Andrews, LS; Banton, MI; Clewell, HJ; Csanády, G; Filser, JG; Gargas, ML; Graham, CJ; Kirman, CR; Papciak, RJ; Pottenger, LH; Sweeney, LM; Tan, YM, 2009
)
2.04
"Propylene oxide (PO) is a high-volume chemical intermediate that causes a low incidence of nasal tumors in rodents exposed to high concentrations (> or =300 p.p.m.). "( Molecular dosimetry of N7-(2-hydroxypropyl)guanine in tissues of F344 rats after inhalation exposure to propylene oxide.
Faller, T; Filser, JG; Lee, MS; Ranasinghe, A; Ríos-Blanco, MN; Swenberg, JA, 2003
)
1.98
"Propylene oxide (PO) is an important industrial compound and a directly acting mutagen. "( Development of a competitive immunoassay for the determination of N-(2-hydroxypropyl)valine adducts in human haemoglobin and its application in biological monitoring.
Aston, P; Ball, L; Boogaard, P; Jones, A; Will, W,
)
1.57
"Propylene oxide is a nasal toxicant and weak site-of-contact carcinogen in the mouse and rat. "( Nasal NPSH depletion and propylene oxide uptake in the upper respiratory tract of the mouse.
Morris, JB; Pottenger, LH, 2006
)
2.08
"Propylene oxide (PO) is a DNA-reactive genotoxic agent; that is, it reacts with DNA to produce lesions in the genetic material. "( Propylene oxide: genotoxicity profile of a rodent nasal carcinogen.
Albertini, RJ; Sweeney, LM, 2007
)
3.23
"Propylene oxide (PO) is a widely used industrial reagent which is mutagenic and carcinogenic. "( Propylene oxide mutagenesis at template cytosine residues.
Koenig, KL; Singh, J; Snow, ET; Solomon, JJ, 1994
)
3.17
"Propylene oxide (PO) is a relatively weak mutagen that induces nasal tumor formation in rats during long-term inhalation studies at high exposures (> or =300 p.p.m.), concentrations that also cause cytotoxicity and increases in cell proliferation. "( Quantitation of DNA and hemoglobin adducts and apurinic/apyrimidinic sites in tissues of F344 rats exposed to propylene oxide by inhalation.
Faller, TH; Filser, JG; Kessler, W; Kreuzer, PE; Nakamura, J; Ranasinghe, A; Ríos-Blanco, MN; Swenberg, JA, 2000
)
1.96
"Propylene oxide (PO) is a direct-acting mutagen and rodent carcinogen. "( Reactions of propylene oxide with 2'-deoxynucleosides and in vitro with calf thymus DNA.
Fedyk, J; Mukai, F; Segal, A; Solomon, JJ, 1988
)
2.09

Toxicity

ExcerptReferenceRelevance
" No exposure-related effects were noted with respect to maternal water consumption, organ weights, cesarean section, or fetal morphological observations with the sole exception of increased frequency of seventh cervical ribs in fetuses at the maternally toxic exposure level of 500 ppm."( Inhalation developmental toxicity study of propylene oxide in Fischer 344 rats.
Harris, SB; Ridlon, SA; Schardein, JL; Ulrich, CE, 1989
)
0.54
" PPO at 100 mm Hg was toxic to all four species tested: Tribolium castaneum (Herbst), Plodia interpunctella (Hübner), Ephestia cautella (Wlk."( Toxicity of propylene oxide at low pressure against life stages of four species of stored product insects.
Azrieli, A; Dias, R; Finkelman, S; Isikber, AA; Navarro, S; Rindner, M, 2004
)
0.7
" It is highly likely that critical, limiting steps in any given mechanistic pathway may become overwhelmed with increasing exposures, signaling the emergence of new modalities of toxic tissue injury at these higher doses."( Dose-dependent transitions in mechanisms of toxicity: case studies.
Andersen, ME; Bogdanffy, MS; Bus, JS; Cohen, SD; Conolly, RB; David, RM; Doerrer, NG; Dorman, DC; Gaylor, DW; Hattis, D; Rogers, JM; Setzer, RW; Slikker, W; Swenberg, JA; Wallace, K, 2004
)
0.32
" It is suggested that the gel formulation containing sodium lauryl sulfate is safe for most tissues that could be exposed to the product under normal use."( Subchronic (26- and 52-week) toxicity and irritation studies of a novel microbicidal gel formulation containing sodium lauryl sulfate in animal models.
Bergeron, MG; Bussières, M; Laforest, G; Piret, J, 2008
)
0.35
" These toxic tissue responses occur in the same anatomical regions in rodents as do the PO-induced tumors."( Propylene oxide: genotoxicity profile of a rodent nasal carcinogen.
Albertini, RJ; Sweeney, LM, 2007
)
1.78
" The partial modification of available cationic centers up to 100% is predominantly accompanied by a significant gradual reduction in polycation adverse effects, while ability of complex formation with plasmid DNA is being preserved."( Propoxylation of cationic polymers provides a novel approach to controllable modulation of their cellular toxicity and interaction with nucleic acids.
Abdullin, TI; Badeev, YV; Salakhieva, DV; Shevchenko, VD; Shtyrlin, YG; Yergeshov, AA, 2016
)
0.43

Bioavailability

ExcerptReferenceRelevance
" The IN administration of Poloxamer 407 and TDM based formulation showed a systemic bioavailability of 29."( Poly(ethylene oxide/propylene oxide) copolymer thermo-reversible gelling system for the enhancement of intranasal zidovudine delivery to the brain.
Kim, K; Ved, PM, 2011
)
0.69
" One of them is the close relationship of drug's bioavailability with solubility, dissolution rate and permeability."( Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin.
Alves, TFR; Chaud, MV; da Silva Pontes, K; das Neves Lopes, FCC; Junior, JMO; Komatsu, D; Rebelo, MA; Santos, C; Severino, P; Souza, JF, 2018
)
0.77
"Thus, these SDs, specifically CUR:P-407 1:2 w/w, can overcome the barriers of poor bioavailability to reap many beneficial properties."( Crystalline Ethylene Oxide and Propylene Oxide Triblock Copolymer Solid Dispersion Enhance Solubility, Stability and Promoting Time- Controllable Release of Curcumin.
Alves, TFR; Chaud, MV; da Silva Pontes, K; das Neves Lopes, FCC; Junior, JMO; Komatsu, D; Rebelo, MA; Santos, C; Severino, P; Souza, JF, 2018
)
0.77

Dosage Studied

ExcerptRelevanceReference
" Germination was improved slightly up to a dose of 8 kGy but gradually decreased with increase in dosage to 15 kGy of gamma irradiation."( Effect of surface sterilization, fumigation and gamma irradiation on the microflora and germination of barley seeds.
Lacey, J; Ramakrishna, N; Smith, JE, 1991
)
0.28
"1 mg single dosage per mouse) once per week to groups of 100 female NMRI mice respectively."( [Carcinogenic activity of ethylene oxide and its reaction products 2-chloroethanol, 2-bromoethanol, ethylene glycol and diethylene glycol. I. Carcinogenicity of ethylene oxide in comparison with 1,2-propylene oxide after subcutaneous administration in mic
Dunkelberg, H, 1981
)
0.45
" In Section 4 we show how to take advantage of Cox's "proportional hazards model" in establishing approximate dose-response relationships."( [On the statistical analysis of long-term tests for carcinogenesis by means of the random censorship model (author's transl)].
Dunkelberg, H; Wellek, S, 1981
)
0.26
" However, the lack of a dose-response relationship suggests that this effect may not be related to oxide exposure."( Neurophysiological and neuropathological evaluation of primates exposed to ethylene oxide and propylene oxide.
Brightwell, WS; Burg, JR; Johnson, BL; Lynch, DW; Madden, G; Russo, JM; Setzer, JV; Sprinz, H,
)
0.35
" The dose-response of ECH was about five times higher compared with that of PO (211 vs."( Propylene oxide and epichlorohydrin induce DNA strand breaks in human diploid fibroblasts.
Cedervall, B; Dusinská, M; Kolman, A; Näslund, M; Spivak, I, 1997
)
1.74
" This flat dose-response relationship is primarily the result of efficient repair of EO-induced DNA adducts in the fertilized egg, as was evident from the up to 40-fold or 240-fold increased mutant frequencies above NER- or NER+ background levels, respectively, in crosses with NER- females."( Genotoxic effects of inhaled ethylene oxide, propylene oxide and butylene oxide on germ cells: sensitivity of genetic endpoints in relation to dose and repair status.
Nivard, MJ; Vogel, EW, 1998
)
0.56
" The dose-response for accumulation of DNA adducts was similar to that obtained for Hb adducts."( Exposure-dependent accumulation of N-(2-hydroxypropyl)valine in hemoglobin of F344 rats exposed to propylene oxide by the inhalation route.
Filser, JG; Lee, MS; Ranasinghe, A; Ríos-Blanco, MN; Swenberg, JA; Upton, P, 2002
)
0.53
" The non-linear dose-response relationship for mutations could therefore not be explained by a reduced inhalation or increased detoxification at higher exposure levels."( Mutagenic activity of ethylene oxide and propylene oxide under XPG proficient and deficient conditions in relation to N-7-(2-hydroxyalkyl)guanine levels in Drosophila.
Czene, K; Nivard, MJ; Segerbäck, D; Vogel, EW, 2003
)
0.58
" Within the range of concentrations where the dose-response curves for adduct formation are linear, the relationship between exposure dose and resulting tissue doses could be based equally well on adduct data from the short-term exposure as on adduct data from the prolonged exposure."( Dosimetry by means of DNA and hemoglobin adducts in propylene oxide-exposed rats.
Csanády, GA; Czene, K; Faller, TH; Filser, JG; Kessler, W; Lee, MS; Osterman-Golkar, S; Pérez, HL; Segerbäck, D, 2003
)
0.57
"Experience with dose response and mechanisms of toxicity has shown that multiple mechanisms may exist for a single agent along the continuum of the full dose-response curve."( Dose-dependent transitions in mechanisms of toxicity: case studies.
Andersen, ME; Bogdanffy, MS; Bus, JS; Cohen, SD; Conolly, RB; David, RM; Doerrer, NG; Dorman, DC; Gaylor, DW; Hattis, D; Rogers, JM; Setzer, RW; Slikker, W; Swenberg, JA; Wallace, K, 2004
)
0.32
" A beta-Poisson model for the dose-response relationship for Salmonella was obtained from published literature."( Monte Carlo simulations assessing the risk of salmonellosis from consumption of almonds.
Danyluk, MD; Harris, LJ; Schaffner, DW, 2006
)
0.33
" Thus, the modified Dioscorea starches showed potentials for development as new excipients in solid dosage form design, and they could be useful as disintegrants or for Soft tableting."( Evaluation of the material and tablet formation properties of modified forms of Dioscorea starches.
Odeku, OA; Picker-Freyer, KM, 2009
)
0.35
" When tartaric acid is dosed at room temperature and immediately cooled to 100 K for imaging, individual bitartrate molecules were found."( Chemisorptive enantioselectivity of chiral epoxides on tartaric-acid modified Pd(111): three-point bonding.
Mahapatra, M; Tysoe, WT, 2015
)
0.42
" This review summarizes and evaluates the status of dose-response data for DNA adducts and mutations from recent experimental work with standard mutagenic agents and ethylene oxide and propylene oxide, and the importance for risk assessment."( Understanding the importance of low-molecular weight (ethylene oxide- and propylene oxide-induced) DNA adducts and mutations in risk assessment: Insights from 15 years of research and collaborative discussions.
Boysen, G; Brown, K; Cadet, J; Fuchs, RP; Johnson, GE; Pottenger, LH; Swenberg, JA, 2019
)
0.94
"036) significantly increased risk of dyslexia, with a dose-response relationship (P-trend = 0."( Association between urinary propylene oxide metabolite and the risk of dyslexia.
Feng, Y; Jiang, Q; Liu, Q; Meng, H; Song, R; Wan, Y; Wu, X; Xiang, Z; Xiao, P; Xie, X; Zhang, J; Zhu, B; Zhu, K, 2022
)
1.02
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Occurs in Manufacturing (1 Items)

ItemProcessFrequency
Snackscore-ingredient1

Drug Classes (1)

ClassDescription
epoxideAny cyclic ether in which the oxygen atom forms part of a 3-membered ring.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (346)

TimeframeStudies, This Drug (%)All Drugs %
pre-199063 (18.21)18.7374
1990's79 (22.83)18.2507
2000's105 (30.35)29.6817
2010's82 (23.70)24.3611
2020's17 (4.91)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 60.64

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index60.64 (24.57)
Research Supply Index5.88 (2.92)
Research Growth Index4.59 (4.65)
Search Engine Demand Index102.98 (26.88)
Search Engine Supply Index2.01 (0.95)

This Compound (60.64)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews16 (4.49%)6.00%
Case Studies5 (1.40%)4.05%
Observational0 (0.00%)0.25%
Other335 (94.10%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]